Harrow Health, Inc. 13D and 13G filings for Eton Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-30 07:00 am Sale | 2024-04-26 | 13D | Eton Pharmaceuticals, Inc. ETON | HARROW INC. HROW | 0 0.000% | -1,982,000 (Position Closed) | Filing |
| 2022-01-28 4:05 pm Sale | 2021-04-12 | 13D | Eton Pharmaceuticals, Inc. ETON | HARROW INC. HROW | 1,982,000 8.100% | -1,518,000 (-43.37%) | Filing |